List of Ultragenyx Pharmaceutical patents

List of Ultragenyx Pharmaceutical patents

List of Bulgari patents

List of Inductotherm Corp. patents

List of Texas State University patents

List of companies in Ignition Partners's investment portfolio

List of companies in Cogito Capital Partners's investment portfolio

Patents where

Current Assignee

Name

is

Ultragenyx Pharmaceutical

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11377643 Therapeutics for glycogen storage disease type III		Ultragenyx Pharmaceutical	Ultragenyx Pharmaceutical		United States Patent and Trademark Office	11377643	July 5, 2022
	‌ US Patent 11332438 Creatine prodrugs, compositions and methods of use thereof	Patent 11332438 was granted and assigned to Ultragenyx Pharmaceutical on May, 2022 by the United States Patent and Trademark Office.	Ultragenyx Pharmaceutical	Ultragenyx Pharmaceutical		United States Patent and Trademark Office	11332438	May 17, 2022
	‌ US Patent 10385085 Crystal forms of sialic acid or salt or solvate thereof	Patent 10385085 was granted and assigned to Ultragenyx Pharmaceutical on August, 2019 by the United States Patent and Trademark Office.	Ultragenyx Pharmaceutical	Ultragenyx Pharmaceutical		United States Patent and Trademark Office	10385085	August 20, 2019
	‌ US Patent 9457067 Sialylated glycoprotein compositions and uses thereof	Patent 9457067 was granted and assigned to Ultragenyx Pharmaceutical on October, 2016 by the United States Patent and Trademark Office.	Ultragenyx Pharmaceutical	Ultragenyx Pharmaceutical		United States Patent and Trademark Office	9457067	October 4, 2016
	‌ US Patent 9457068 Sialylated glycoprotein compositions and uses thereof	Patent 9457068 was granted and assigned to Ultragenyx Pharmaceutical on October, 2016 by the United States Patent and Trademark Office.	Ultragenyx Pharmaceutical	Ultragenyx Pharmaceutical		United States Patent and Trademark Office	9457068	October 4, 2016
	‌ US Patent 9687532 Sialylated glycoprotein compositons and uses thereof	Patent 9687532 was granted and assigned to Ultragenyx Pharmaceutical on June, 2017 by the United States Patent and Trademark Office.	Ultragenyx Pharmaceutical	Ultragenyx Pharmaceutical		United States Patent and Trademark Office	9687532	June 27, 2017
	‌ US Patent 10889607 Sialic acid analogs	Patent 10889607 was granted and assigned to Ultragenyx Pharmaceutical on January, 2021 by the United States Patent and Trademark Office.	Ultragenyx Pharmaceutical	Ultragenyx Pharmaceutical		United States Patent and Trademark Office	10889607	January 12, 2021
	‌ US Patent 10065981 Sialic acid analogs	Patent 10065981 was granted and assigned to Ultragenyx Pharmaceutical on September, 2018 by the United States Patent and Trademark Office.	Ultragenyx Pharmaceutical	Ultragenyx Pharmaceutical		United States Patent and Trademark Office	10065981	September 4, 2018
	‌ US Patent 10457701 Sialic acid analogs	Patent 10457701 was granted and assigned to Ultragenyx Pharmaceutical on October, 2019 by the United States Patent and Trademark Office.	Ultragenyx Pharmaceutical	Ultragenyx Pharmaceutical		United States Patent and Trademark Office	10457701	October 29, 2019
	‌ US Patent 9554987 Methods and formulations for treating sialic acid deficiencies	Patent 9554987 was granted and assigned to Ultragenyx Pharmaceutical on January, 2017 by the United States Patent and Trademark Office.	Ultragenyx Pharmaceutical	Ultragenyx Pharmaceutical		United States Patent and Trademark Office	9554987	January 31, 2017
	‌ US Patent 8840926 Sialic acid analogs	Patent 8840926 was granted and assigned to Ultragenyx Pharmaceutical on September, 2014 by the United States Patent and Trademark Office.	Ultragenyx Pharmaceutical	Ultragenyx Pharmaceutical		United States Patent and Trademark Office	8840926	September 23, 2014
	‌ US Patent 9221858 Sialic acid analogs	Patent 9221858 was granted and assigned to Ultragenyx Pharmaceutical on December, 2015 by the United States Patent and Trademark Office.	Ultragenyx Pharmaceutical	Ultragenyx Pharmaceutical		United States Patent and Trademark Office	9221858	December 29, 2015
	‌ US Patent 9241896 Methods and formulations for treating sialic acid deficiencies	Patent 9241896 was granted and assigned to Ultragenyx Pharmaceutical on January, 2016 by the United States Patent and Trademark Office.	Ultragenyx Pharmaceutical	Ultragenyx Pharmaceutical		United States Patent and Trademark Office	9241896	January 26, 2016
	‌ US Patent 9511015 Methods and formulations for treating sialic acid deficiencies	Patent 9511015 was granted and assigned to Ultragenyx Pharmaceutical on December, 2016 by the United States Patent and Trademark Office.		Ultragenyx Pharmaceutical		United States Patent and Trademark Office	9511015	December 6, 2016
	‌ US Patent 11013774 Methods of heat inactivation of adenovirus	Patent 11013774 was granted and assigned to Ultragenyx Pharmaceutical on May, 2021 by the United States Patent and Trademark Office.	Ultragenyx Pharmaceutical	Ultragenyx Pharmaceutical		United States Patent and Trademark Office	11013774	May 25, 2021
	‌ US Patent 11753369 Creatine prodrugs, compositions and methods of use thereof	Patent 11753369 was granted and assigned to Ultragenyx Pharmaceutical on September, 2023 by the United States Patent and Trademark Office.	Ultragenyx Pharmaceutical	Ultragenyx Pharmaceutical		United States Patent and Trademark Office	11753369	September 12, 2023
	‌ US Patent 12018288 Engineered producer cell lines and methods of making and using the same	Patent 12018288 was granted and assigned to Ultragenyx Pharmaceutical on June, 2024 by the United States Patent and Trademark Office.	Ultragenyx Pharmaceutical	Ultragenyx Pharmaceutical		United States Patent and Trademark Office	12018288	June 25, 2024
	‌ US Patent 11944658 Methods of heat inactivation of adenovirus	Patent 11944658 was granted and assigned to Ultragenyx Pharmaceutical on April, 2024 by the United States Patent and Trademark Office.	Ultragenyx Pharmaceutical	Ultragenyx Pharmaceutical		United States Patent and Trademark Office	11944658	April 2, 2024

18 results

0 selected

18 results

0 selected